Clinical trial
Effect of Risedronate on Bone Morbidity in Fibrous Dysplasia of Bone
NCT00445575 · Institut National de la Santé Et de la Recherche Médicale, France, Other · Completed
Key facts
| NCT number | NCT00445575 |
|---|---|
| Title | Effect of Risedronate on Bone Morbidity in Fibrous Dysplasia of Bone |
| Official title | Effect of Risedronate on Bone Morbidity in Fibrous Dysplasia of Bone |
| Acronym | PROFIDYS |
| Lead sponsor | Institut National de la Santé Et de la Recherche Médicale, France, Other |
| Collaborators | ZonMw: The Netherlands Organisation for Health Research and Development Cliniques universitaires Saint-Luc- Université Catholique de Louvain Charite University, Berlin, Germany |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Fibrous Dysplasia of Bone |
| Intervention type | Drug |
| Interventions | risedronate, placebo |
| Enrollment | 80 |
| Start date | Jul 22, 2007 |
| Primary completion | Dec 1, 2017 |
| Completion | Dec 7, 2017 |
| First posted | Mar 9, 2007 |
| Last update posted | Aug 30, 2021 |
| Countries | Belgium, France, Germany, Netherlands |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: